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B ions represent an important type of fragment ions derived from protonated peptides by
cleavage of an amide bond with N-terminal charge retention. Such species have also been
discussed as key intermediates during cyclic peptide fragmentation. Detailed structural
information on such ion types can facilitate the interpretation of multiple step fragmentations
such as the formation of inner chain fragments from linear peptides or the fragmentation of
cyclic peptides. The structure of different b2 ion isomers was investigated with collision-
induced dissociations (CID) in combination with hydrogen/deuterium (H/D) exchange of the
acidic protons. Special care was taken to investigate fragment ions derived from pure
gas-phase processes. Structures deduced from the results of the CID analysis were compared
with structures predicted on the basis of quantum chemical density functional theory (DFT)
calculations to be most stable. The results pointed to different types of structures for b2 ion
isomers of complementary amino acid sequences. Either the protonated oxazolone structure or
the N-terminally protonated immonium ion structure were proposed on the basis of the CID
results and the DFT calculations. In addition, the analysis of different selectively N-alkylated
peptide analogs revealed mechanistic details of the processes generating b ions. (J Am Soc
Mass Spectrom 1998, 9, 1002–1011) © 1998 American Society for Mass Spectrometry
The analysis of the primary structure of peptideswith tandem mass spectrometry was establishedafter the introduction of desorption ionization
methods, especially fast atom bombardment (FAB) to
mass spectrometry [1]. These methods allow ionization
of underivatized peptides, which are then subjected to
collision-induced dissociations (CID). The analysis of
the resulting fragmentation patterns has been used to
deduce peptide sequences and is especially useful for
the analysis of posttranslational modifications of pep-
tides and proteins [2, 3]. It has been reported that
peptide sequences could be assigned by the rationaliza-
tion of the fragmentation resulting from peptide back-
bone cleavages [4, 5]. Bn ions and y(N2n) ions with n and
N indicating the number of the current amino acid and
the total number of residues of the peptide, respec-
tively, play a key role in the interpretation of mass
spectral peptide fragmentation patterns, because they
represent the products of the cleavage of the amide
bond n associated with N- or C-terminal charge reten-
tion, respectively (Scheme 1a).
Knowledge on the structure and fragmentation be-
havior of y and b ions is of crucial importance when
peptides are sequenced with mass spectrometric tech-
niques employing consecutive fragmentation reactions
such as low energy CID and multiple stage tandem
mass spectrometry (MSn) [6, 7]. Furthermore, b ions
were found to be the ring opening products and major
fragmentation products of protonated cyclic peptides [8].
A number of reports dealing with the structural investi-
gations of y ions [9, 10] and b ions [10–14] appeared.
y ions were identified as N-terminally truncated
protonated peptide ions [9, 10]. In contrast, an acylium
ion structure (Scheme 1b) [2] was assigned to b ions.
Cordero et al. demonstrated by FAB combined with
CID mass spectral analysis that the structure of the
Ala–Ala b2 ion was different from the structure of the
corresponding protonated diketopiperazine [10]. This
observation was also reported for b2 ions consisting of
two Gly residues [11] or one Gly and one Pro residue
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[12]. The protonated oxazolone structure was proposed
for the first time for the Ala–Ala b2 ion [10]. In view of
these considerations the structure of N-benzoyl glycine
was investigated as a model for b ions. Identical CID
mass spectra were observed for the b ion derived from
N-benzoyl–Gly–OH 5 and protonated 2-phenyl-5-ox-
azolone 6 (Scheme 2) [13]. This was the first experimen-
tal evidence for the oxazolone structure of a b ion.
However, the N-benzoyl glycine b ion lacked the N-
terminal amino group of longer b ions obtained from
unmodified peptides and, therefore, could not serve as
a model system for b ion structures of peptides in
general. Furthermore, the investigation of isomeric b2
ions derived from H–Gly–Pro–Gly–OH or H–Pro–Gly–
Gly–OH provided evidence for differences in their
structures [15].
Yaclin et al. studied the properties of a variety of bn
ions [13, 14] by kinetic energy release measurements
and low energy CID. On the basis of kinetic energy
release measurements they concluded that bn ions with
n 5 3, 4 also exhibit a protonated oxazolone structure.
The release of a kinetic energy (T1/2) of 0.3–05. eV
correlated with the energy difference between the un-
stable acylium ion (bn) and the resulting an ion and
neutral CO [13]. However, this observation did not
provide evidence for the oxazolone structure because
kinetic energy release measurements reflect the proper-
ties of unstable ions in the gas phase [16]. A CID based
comparison of these bn ions with oxazolone reference
compounds was not possible because of the lack of
oxazolones other than 2-phenyl-5-oxazolone. Nold et al.
applied high energy CID to protonated 2-phenyl-5-
oxazolone 6 and found a significant signal for loss of
CO2 [17]. They analyzed the b2 ions with the sequence
Gly–Leu and Leu–Gly for this fragmentation and found
signals of relatively low abundance.
Investigation of the mechanism of b ion formation
may help to understand the b ion structures. The
investigation of selectively N-alkylated peptides after
protonation in the gas phase [18, 19] showed a clear
preference for the formation of the b ions having the
N-alkylated amino acid residue in the C-terminal posi-
tion. On this basis, the relative abundance of the various
bn ions of selectively N-alkylated analogs of the peptide
[Pyr6]–substance P6–11 (Pyr6–SP6–11) have been ana-
lyzed in the present study with tandem mass spectrom-
etry. In addition, hydrogen/deuterium (H/D) exchange
of the acidic hydrogen atoms [9, 20–22] was performed
with a number of tripeptides and a mechanism for b ion
formation was proposed on these experimental data.
Various heteromeric b2 ions composed of two differ-
ent amino acids such as Ala, Gly, Pro, and N-methyl
glycine (sarcosine, Sar), were chosen as models for b
ions containing amino acid residues with uncharged
side chains. The structures were analyzed with CID of
the ions obtained with electrospray (ES). Especially, the
comparison of the CID mass spectra of b2 ions with
reversed amino acid sequences was used to obtain
evidence for b ion structures. Furthermore, hydrogen/
deuterium (H/D) exchange of the acidic hydrogen
atoms [9, 20–22] was carried out in order to study the
mechanisms of b2 ion decomposition. Finally, the struc-
tures deduced from the experimental results were ana-
lyzed with quantum chemical calculations for their
relative energetic stability.
Scheme I. (a) Reported types of mass spectrometric peptide
backbone fragmentation. (b) Primary and secondary amide bond
cleavages of protonated peptides during mass spectrometric anal-
ysis.
Scheme 2. Formation and identification of protonated 2-phenyl-
5-oxazolone from N-benzoyl–Gly–Gly–OH.
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Experimental
All mass spectral data were recorded on a Micromass
AutoSpec-T tandem mass spectrometer equipped with
a 3 in. focal plane detector. Data were recorded and
processed using the OPUS data system.
ES Mass Spectra
The Micromass ES interface and the operation condi-
tions were recently described [23]. The interface was
additionally equipped with a skimmer lens. The ions
were accelerated between the skimmer and the source
slit with a potential difference of 4 kV. The spray
chamber was heated to 30°C. Higher temperatures were
avoided to prevent heat-induced molecular ion frag-
mentation. The sampling cone voltage and skimmer
lens voltage were initially adjusted to 0 V above the
skimmer potential (“lower values”). This setting mini-
mized the fragmentation of the molecular ions. An
optimal yield of fragment ions was achieved with the
sampling cone and the skimmer lens set to 50 and 60 V,
respectively, above the skimmer potential (“higher val-
ues”). These settings provided the best compromise
between high yields of fragments by collisions between
the sampling cone and the skimmer (CSCID) and un-
wanted scattering of the ion beam. Samples were
delivered by loop injection as previously described
[23]. The peptide samples were dissolved to a final
concentration between 0.1 and 1 mg/ml (0.5–5 mM)
in a mixture of 49.5% methanol, 49.5% water, and 1%
acetic acid.
FAB Mass Spectra
Samples were ionized with a Cs1 primary ion beam of
20 keV translational energy (12 keV effective transla-
tional energy) and 1–2 mA emission. The secondary ions
were accelerated with 8 kV at a source housing pressure
less than 5 3 1026 mbar. The Pyr6–SP6–11 analogs were
dissolved in 1 mL formic acid and mixed with 5 mL
glycerol. One mL of this solution was applied to the
stainless steel probe tip.
CID Mass Spectra
CID mass spectra were recorded on the array detector.
The parent ion beam was focused through the collector
slit of MS1 with a mass resolution of 2000. The array
detector was set to a 15° angle resulting in a mass ratio
of 1.1:1. The gas cell was operated at 50% of the ion
energy potential, and the parent ion beam was attenu-
ated to 30% intensity with approximately 2 3 1026 mbar
helium. The molecular ions of the Pyr6–SP6–11 analogs
were fragmented with 2.5 3 1026 mbar argon instead of
the collision gas helium.
H/D Exchange
Each peptide (100 mg) was dried in a speed vac concen-
trator, dissolved in 100 mL of a mixture of 49.5%
deuterium oxide (99.8% D), 49.5% methanol d1 (99.5%
D), and 1% acetic acid d1 (99.5% D). After 2 h of
incubation at room temperature, the samples were
dried again and finally dissolved in 100 mL of the
solvent described above. Deuterated peptides were
delivered in the deuterated solvent. The yield of deu-
teration of peptides was between 80% and 90% depend-
ing on the number of acidic hydrogens. For MS/MS
experiments the completely exchanged parent ion was
selected with the first MS and selectively subjected to
CID.
Peptides
Peptides were purchased from Bachem AG Heidelberg.
The samples were used as received. Pro–Gly–b-naph-
thylamide was synthesized from tBoc–Pro–OSu and
Gly–b-naphthylamide also obtained from Bachem. The
Pyr6–SP6–11 analogs were synthesized by Professor
Gilon (Hebrew University of Jerusalem, Israel). The
structures of these peptides were confirmed earlier by a
combination of mass spectrometry and amino acid
analysis [18, 24].
Quantum Chemical Calculations
The global minimum in the conformational space of
each isomer was located using the conformational anal-
ysis routine of the program Spartan 3.0. [20]. All flexible
bonds in each structure were systematically rotated in
60° increments and the resulting geometries were opti-
mized at the semiempirical PM3 level of theory [25].
The geometries of the resulting structures were reopti-
mized employing approximate density functional the-
ory [26] using the DGauss program [27]. The BLYP
functional was employed, which includes nonlocal cor-
rections for exchange [28] and correlation [29]. For these
calculations a polarized valence double zeta basis set
was used in combination with a pseudopotential for the
1s electrons of C, O, and N (DZVP), as implemented in
DGauss. All energies and structures discussed refer to
this level of theory. Structures appearing with a com-
puted energy difference of less than approximately 15
kJ/mol cannot safely be distinguished in their stability
because of the expected level of accuracy provided by
the BLYP calculations.
Results
Mechanism of b Ion Formation
The influence of amide bond protonation on b ion
formation was investigated with the selectively alky-
lated analogs of the peptide Pyr6–SP6–11 (Table 1). These
peptides are especially well suited for such studies
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because of the missing N-terminal amino group. Thus,
no competition between the amide bond and the N-
terminal amino group for the proton added during
ionization is possible and the effect of amide bond
protonation to bn ion formation can be studied without
such interferences. The enhanced abundance of the bn
ions formed by cleavage of the C-terminal amide bond
of the N-alkylated amino acids was originally observed
in the FAB mass spectra of the selectively alkylated
analogs of the peptide Pyr6–SP6–11 [18] and was even
more pronounced in the CID mass spectra of these
peptides (Table 1). N-alkylation of the amino acid
residue n resulted in a dramatic increase of the relative
abundance of the bn ion. Only a minor increase was
found when methyl was replaced by ethyl or propyl.
Deuteration of the acidic hydrogen atoms [9, 20–22]
and CID mass spectral analysis was carried out with all
peptides used as precursors for the b2 ions investigated
(Tables 2 and 3). No scrambling between acidic and
nonacidic hydrogen atoms during the formation of b
ions was observed. In general, the b ions contained the
number of acidic hydrogens as deuterium atoms,
whereas the neutral C-terminal fragment carried the
additional deuterium atom added by ionization.
On the basis of the above observations, a mechanism
for b ion formation was proposed and exemplified on
the tripeptide H–Gly–Ala–Gly–OH 8 (Figure 1). The
carbonyl oxygen of the amide bond covering the mostly
basic a-amino group was prefereably protonated/deu-
terated [30]. This oxygen attacked the next C-terminally
located carbonyl carbon atom because of its increased
nucleophilicity and ejected the neutral H–Gly–OH 9
associated with the formation of the protonated ox-
azolone 10. During this process the hydrogen/deute-
rium atom was transferred to the amino group of the
C-terminal Gly residue 9, and the amide bond was
cleaved. Despite this preferred protonation site, the
other amide bond and the N-terminal amino group
were also protonated to a certain extent, as could be
deduced from the occurrence of the Gly a1 and y3a3
immonium ions (m/z 30) [31–33]. It was concluded that
the proton may migrate along the peptide backbone
through hydrogen shifts between the carbonyl oxygens.
Figure 1. (a) Proposed mechanism for the formation of b ions
from protonated peptides. (b) CAD mass spectrum of protonated
H–Gly–Ala–Gly–OH.
Table 1. Change in the relative abundance of bn ions (sum of b ion current is normalized to 100%) of the CAD mass spectra
induced by selective N-alkylation of the Pyr6–SP6–11 analogs
Pyr6–SP6–11 analog b2 ion (%) b3 ion (%) b4 ion (%) b5 ion (%)
Pyr–Phe–Phe–Gly–Leu–MetNH2 7.7 14.4 29.8 48.1
Pyr–NMePhe–Phe–Gly–Leu–MetNH2 68.0 2.7 8.9 20.4
Pyr–Phe–NMePhe–Gly–Leu–MetNH2 3.7 73.5 5.9 16.9
Pyr–Phe–NEtPhe–Gly–Leu–MetNH2 2.5 82.0 4.9 10.6
Pyr–Phe–NPrPhe–Gly–Leu–MetNH2 0.9 84.0 2.5 12.6
Pyr–Phe–Phe–Sar–Leu–MetNH2 4.9 3.5 69.4 22.2
Pyr–Phe–Phe–Gly–NMeLeu–MetNH2 3.6 4.5 2.6 89.3
Table 2. Peptides used as precursors of heteromeric b2 ions
and their cyclic isomers
Target peptide ion m/z Peptide precursor
Ala–Gly b2 ion 129 H–Ala–Gly–Gly–OH
Gly–Ala b2 ion 129 H–Gly–Ala–Gly–OH
c[Ala–Gly] 1 H1 129 c[Ala–Gly]
Gly–Sar b2 ion 129 H–Gly–Sar–Sar–OH
Sar–Gly b2 ion 129 H–Sar–Gly–Gly–OH
Gly–Pro b2 ion 155 H–Gly–Pro–Gly–OH
Gly–Pro b2 ion 155 H–Gly–Pro–b-naphthylamide
Pro–Gly b2 ion 155 H–Pro–Gly–Gly–OH
Pro–Gly b2 ion 155 H–Pro–Gly–b-naphthylamide
c[Gly–Pro] 1 H1 155 c[Gly–Pro]
Table 3. Peptides used as precursors of homomeric b2 ions
and their cyclic isomers
Target peptide ion m/z Peptide precursor
Gly–Gly b2 ion 115 H–Gly–Gly–Gly–OH
Gly–Gly b2 ion 115 H–Gly–Gly–Ala–OH
Gly–Gly b2 ion 115 H–Gly–Gly–b-naphthylamide
c[Gly–Gly] 1 H1 115 c[Gly–Gly]
Ala–Ala b2 ion 143 H–Ala–Ala–Gly–OH
Ala–Ala b2 ion 143 H–Ala–Ala–Ala–OH
Ala–Ala b2 ion 143 H–Ala–Ala–b-naphthylamide
c[Ala–Ala] 1 H1 143 c[Ala–Ala]
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Characterization of Isomeric b2 Ions by Their CID
Mass Spectra
The ES mass spectra of the peptides used for the
generation of the b2 ions (Table 2) were recorded with
the “low settings” and the “high settings” of the sampling
cone and the skimmer lens voltage as described in the
Experimental Procedures. In addition, the ES interface
was operated at low temperature to prevent heat-
induced fragmentation. Depending on the stability of
the peptide molecular ion, the relative intensity of the
most abundant fragment varied between 0.1% and 5%
with the low settings of the sampling cone and skimmer
lens voltages. For all peptides, the intensity of the most
abundant fragment ion was enhanced by a factor of 5 to
10 compared to the intensity of the molecular ion when
the high settings were used instead of the low settings.
This effect demonstrated that the peptide fragments
were produced by gas-phase dissociations and, there-
fore, those ions could be used as reference ions for MSn
investigations of fragment ions obtained in the collision
cell of a sector tandem mass spectrometer [17, 34, 35] or
the cell in FTICR or ion trap mass spectrometers [7].
The CID mass spectra of the heteromeric b2 ions
listed in Table 2 were obtained after ES CSCID fragmen-
tation. In general, b2 ions of the same amino acid
sequence derived from precursor peptides carrying a
different C-terminal leaving group such as Gly–OH,
Ala–OH, or b-naphthylamide (Tables 2 and 3), exhib-
ited identical CID mass spectral patterns.
The CID mass spectra of the isomeric b2 ions of Ala
and Gly were not changed to a great extent when Ala
was replaced by the isomeric Sar residue in Gly–Ala
(Figure 2a, b) as well as Ala–Gly (Figure 4c, d). All CID
mass spectra exhibited an abundant signal for the loss
of CO (m/z 101). The Ala or Sar immonium ion
fragment (m/z 44) [31, 32] represented the base peak in
these spectra and the b 2 ion isomers having Gly in the
N-terminal position produced additionally an abun-
dant Gly a1 immonium ion fragment (m/z 30) [31, 32].
No evidence for the formation of the diketopiperazine
could be found when the CID mass spectrum of pro-
tonated c[Ala–Gly] (data not shown) was compared
with the CID mass spectra in Figure 2a, c.
The CID mass spectra were also screened for the
appearance of a fragment ion representing the loss of
CO2, which may be useful to identify the protonated
oxazolone structure [17]. The fragment ion m/z 71 (3%,
Figure 3a) in the CID mass spectrum of the Gly–Gly b2
ion was shifted after H/D exchange to m/z 72. In the
case of a CO2 loss this signal had to be shifted to m/z
74. A similar observation was made for m/z 99 of the
b2 ion of Ala–Ala (2%, Figure 3b), which was shifted to
m/z 101 after H/D exchange. No significant signals
corresponding to the loss of CO2 were found in the CID
mass spectra of the b2 ions of the Gly–Ala and the
Gly–Sar isomers (m/z 85, Figure 2), and the Gly–Pro
isomers (m/z 111, data not shown). In addition, the
CID mass spectrum of protonated 2-phenyl-5-ox-
azolone 6 formed by loss of H–Gly–OH from proton-
ated Hippuryl-Gly–OH 5 (Scheme 2) was reproduced
with the CID method used in this paper. A mass
spectral fragmentation pattern similar to that reported
by Nold et al. [17] except for the loss of CO2 was found
(Figure 4). Thus, the loss of CO2 could not be used as an
indicator for the protonated oxazolone structures ana-
lyzed with the CID method used in the present paper.
The protonated oxazolone structure was accepted so
far as the stable structure of b ions [10, 13, 14, 17, 33].
This structure was also expected from the mechanism
presented above (Figure 1). However, the different CID
mass spectral patterns of the isomeric b2 ions could not
be explained on this basis. Thus, fragmentation of the
Gly–Ala b2 ion gave rise to the y2a2 immonium ion
fragment at m/z 44 derived from the C-terminal Ala
residue (Figure 2a). In contrast, the isomeric Ala–Gly b2
ion did not form an y2a2 immonium ion fragment at
m/z 30 derived from the C-terminal Gly residue (Fig-
ure 2c). Such corresponding a1 fragment ion signal was
observed in case of the N-terminal localization of the
Figure 2. CAD mass spectra of isomeric C5H9N2O2
1 ions of
ES-protonated and CS CAD-fragmented (a) H–Gly–Ala–Gly–OH,
(b) H–Gly–Sar–Sar–OH, (c) H–Ala–Gly–Gly–OH, and (d) H–Sar–
Gly–Gly–OH.
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Gly residue in the Gly–Ala b2 ion. Because this differ-
ence in the fragmentation patterns could not be ex-
plained by the protonated oxazolone structure for both
b2 ion isomers, it was speculated that an alternative
structure with N-terminal charge localization could be
valid for the Ala–Gly b2 ion. This consideration was
used as a basis for the DFT calculations.
Analysis of Stable b2 Ion Structures by DFT
Calculations
Initially, different types of possible N-terminally
charged b2 ions structures were analyzed with DFT
calculations. The protonated immonium ion 13 was
found to be by far the most stable isomer. The proton-
ated Ala–Gly diketopiperazine 11, the protonated ox-
azolone structures 10 and 12 and immonium ion struc-
tures 10 and 13 of the Ala–Gly b2 ions were than
compared for their energetic stability on the basis of the
results of DFT calculations. The protonated Ala–Gly
diketopiperazine 11 and the immonium ion structure of
the Ala–Gly isomer 13 were the energetically most
stable isomers (Table 4), whereas the difference of 7
kJ/mol between these structures was not significant,
because a difference of less than 15 kJ/mol is not
significant for the level of theory used in the DFT
calculations. The oxazolone structures of the Gly–Ala
isomer 10 and the Ala–Gly isomer 12 turned out to be
less stable than the protonated diketopiperazine 11 by a
difference of 31 and 42 kJ/mol, respectively (Table 4).
The immonium ion structure of the Gly–Ala isomer 14
was 46 kJ/mol less stable than the protonated dike-
topiperazine 11 (Table 4). For the Ala–Gly b2 ion isomer
the immonium ion form 13 was 35 kJ/mol more stable
than the protonated oxazolone form 12, whereas the
immonium ion form 14 was 15 kJ/mol less stable than
the protonated oxazolone 10 of the Gly–Ala b2 ion
isomer. Furthermore, the protonated diketopiperazine
11 was excluded as b2 ion structure by the CID mass
spectral analysis. Thus, the DFT calculations matched
the predictions from the experimental data. In contrast
to these findings, the protonated oxazolone and immo-
nium ion structure of the Gly–Gly b2 ion were less
stable than the protonated Gly–Gly diketopiperazine by
39 and 40 kJ/mol, respectively. The unsignificant ener-
getic difference of 1 kJ/mol did not allow a distinction
between the oxazolone and immonium ion structure of
the Gly–Gly b2 ion by DFT calculations.
A possible mechanism for the formation of the
immonium ion type b2 ions is outlined for the Ala–Gly
b2 ion (Scheme 3). The protonated oxazolone 12 may
undergo ring opening immediately after its formation
to form the acylium ion transition state 15. This acylium
ion can be stabilized by a hydrogen bridge in the
N-terminal Ala residue. The a-proton of the Ala residue
is transferred in a second step to the free carbonyl group
resulting in the formation of the immonium ion 13. The
possibility of two hydrogen bridges and a wide distri-
bution of the positive charge in the more basic amino
acid residue are the factors stabilizing the immonium
ion 13 over the protonated oxazolone 12 by 35 kJ/mol.
It is speculated that the hydrogen bridge in 15 may
prevent formation of the protonated diketopiperazine
11. However, all experimental data reported so far leave
Figure 3. CAD mass spectra of the C4H7N2O2
1 ion of ES-proton-
ated and CS CAD-fragmented (a) H–Gly–Gly–Gly–OH and the
C6H11N2O2
1 ion of ES-protonated and CS CAD-fragmented (b)
H–Ala–Ala–Ala–OH.
Figure 4. CAD mass spectrum of the C9H8N1O2 ion of ES-
protonated and CS CAD-fragmented Hippuryl–Gly–OH.
Table 4. Structures and relative energies of the most stable
isomeric C5H9N2O2
1 ions from peptides containing Ala and Gly
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no doubt that b2 ions did not undergo rearrangement to
the isomeric diketopiperazine [10–13, 17].
Pathways of b2 Ion Dissociation Monitored by
H/D Exchange
The CID mass spectra of deuterated b2 ions (Table 5)
showed no significant H/D scrambling with respect to
the a1 and y2a2 immonium ion fragments of the amino
acid residues. The primary amines of Ala and Gly
contained two deuterium atoms, whereas the secondary
amines of Sar and Pro contained one deuterium atom.
This observation demonstrated that the y2a2 immonium
ion fragments 19 of the amino acid residues located at
the C-terminal position in the b2 ion 16 were formed in
association with the transfer of one acidic hydrogen
from the N-terminal residue (Scheme 4).
An abundant increase of the a1 Gly immonium ion
cleaved from the protonated oxazolone b2 ions Gly–Ala,
Gly–Sar, and Gly–Pro by a factor of 2.4 to 4.4 relative to
the competing Ala, Sar, or Pro immonium ion frag-
ments was observed after deuterium incorporation (Ta-
ble 5). This effect was not found by CID mass spectral
analysis of the corresponding a2 ions, which were
formed by CO loss of the b2 ions [3]. Thus, the stable a2
ion 17 of, i.e., Gly–Ala or Gly–Sar could not be an
intermediate of the high energy collision-induced frag-
mentation of these oxazolone type b2 ions 16 (Scheme
4). These observations implied an initial transfer of one
proton as the rate determining step (RDS) in the b2 ions
16, which led to the transition states 18 (Scheme 4). The
y2a2 immonium ions 19 were formed by ejection of
neutrals C2H2X1N1O1 (X 5 H/D) and CO from 18.
Because no isotope effect was observed with the Gly–
Ala, and Gly–Sar a2 ions 17, it was concluded that the
acidic hydrogen transfer did not occur as the RDS in the
fragmentation reaction to form the y2a2 ion from the
stable a2 ion. A concerted mechanism would be com-
patible with this observation.
The mechnism for the a1 immonium ion formation
from b2 immonium ions such as 13 was proposed on the
basis of the H/D exchange results (Scheme 5). As
mentioned above, the resulting a1 ion of Ala contained
two deuterium atoms. This observation implied the
transfer of one nonacidic proton located at the carbonyl
Scheme 3. Formation of iommonium ion type b2 ions via an
acylium ion transition state from protonated oxazolone type b2
ions.
Scheme 4. High energy collision induced fragmentation route
for the formation of the C-terminal amino acid immonium ions
from protonated oxazolone type b2 ions.
Scheme 5. Formation of a1 ions from iommonium ion type b2
ions.
Table 5. Changes in mass-to-charge ratio and relative intensity
of the CO loss and the amino acid immonium ions after H/D
exchange in the CAD mass spectra of various b2 ions
b2 ion Nondeuterated fragments Deuterated fragments
Gly–Gly m/z 87 (95%) m/z 90 (90%)
Gly–Gly m/z 30 (100%) m/z 32 (100%)
Ala–Ala m/z 115 (50%) m/z 118 (20%)
Ala–Ala m/z 44 (100%) m/z 46 (100%)
Gly–Ala m/z 101 (60%) m/z 104 (70%)
Gly–Ala m/z 44 (100%) m/z 46 (90%)
Gly–Ala m/z 30 (40%) m/z 32 (100%)
Gly–Sar m/z 101 (35%) m/z 103 (18%)
Gly–Sar m/z 44 (100%) m/z 45 (52%)
Gly–Sar m/z 30 (44%) m/z 32 (100%)
Gly–Pro m/z 127 (75%) m/z 129 (65%)
Gly–Pro m/z 70 (100%) m/z 71 (77%)
Gly–Pro m/z 30 (55%) m/z 32 (100%)
Ala–Gly m/z 101 (23%) m/z 104 (25%)
Ala–Gly m/z 44 (100%) m/z 46 (100%)
Sar–Gly m/z 101 (37%) m/z 103 (28%)
Sar–Gly m/z 44 (100%) m/z 45 (100%)
Pro–Gly m/z 127 (28%) m/z 129 (35%)
Pro–Gly m/z 70 (100%) m/z 71 (100%)
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group or at the a-carbon atom of the C-terminal Gly
residue to the a-position of the N-terminal Ala residue.
For sterical reasons the transfer of the carbonyl hydro-
gen was proposed (Scheme 5).
Discussion
Structure of b Ions
Ambihapathy et al. reported the low energy CID break-
down graphs of the isomeric Gly–Phe and Phe–Gly b2
ions [33]. The Gly immonium ion fragment m/z 30 (a1
or a2y2) was only observed for the Gly–Phe isomer.
Nold et al. showed the high energy CID mass spectra of
the isomeric Gly–Leu and Leu–Gly b2 ions [17]. The Gly
immonium ion fragment m/z 30 (a1 or a2y2) was again
only observed in the CAD mass spectrum of in the
Gly–Leu b2 ion. Both publications confirmed indepen-
dently the results presented here despite the fact that
Nold et al. rationilized m/z 30 as a consecutive frag-
ment of the Leu residue [17].
Ambihapathy et al. used the experimental design
introduced by Yalcin et al. [13, 14] to justify the ox-
azolone structure. Since protonated 2-phenyl-5-ox-
azolone was used to identify the structure of the N-
benzoyl–Gly b2 ion as protonated 2-phenyl-5-oxazolone
the kinetic energy release (T1/2) associated with CO
elimination from protonated 2-phenyl-5-oxazolone was
used as an indicator for the protonated oxazolone
structure. It was found that the T1/2 value of approxi-
mately 0.5 eV matched the predicted energy release
when the unstable acylium ion transition state dissoci-
ated into CO and the a2 ion. Thus, such T1/2 values hint
to an acylium ion transition state [16], but not necessar-
ily to the protonated oxazolone structure. b2 ions of the
immonium ion structure such as 13 may also lose CO
via an acylium ion transition state.
The low energy CID breakdown graphs of various b2
ions also reported by Yalcin et al. and Ambihapathy et
al. [13, 14, 33] are useful to analyze the order of multiple
step fragmentation reactions, but they do not provide
direct evidence for a particular ionic structure. The most
reliable method is the comparison of CID mass spectra
of different reference ions with the ion of unknown
structure. However, our attempts to synthesize refer-
ence oxazolones similar to 2-phenyl-5-oxazolone failed
because of the high reactivity of the a-carbon of the
amino acid in the oxazolone ring. This behavior is well
explained by the use of oxazolones also named azlac-
tones as reactive intermediates for a-alkylation of
amino acids [36, 37]. Therefore, the CID-based compar-
ison of isomeric b2 ions and structure prediction based
on DFT calculations were chosen in the present paper as
tools for the structural analysis.
Nold et al. introduced the CO2 loss, which was
observed in the high energy CID mass spectrum of
2-phenyl-5-oxazolone, as an indicator for the proton-
ated oxazolone structure [17]. This fragment was found
in the CID mass spectrum of the Gly–Leu b2 ion in
convincing significance, but for the Leu–Gly isomer this
fragment (m/z 127) was not significantly separated
from signals occurring at m/z 124 to 126, which
probably arose from Leu side chain fragmentations [38,
39]. In view of the low abundance of such signals
reported for the Leu-containing b2 ions it has to be
considered that the low resolving power of the MIKES
technique used by these authors hindered an unambig-
uous interpretation of the CID mass spectra.
Thus far, no direct evidence for the oxazolone struc-
ture of larger b ions has been provided. It must be
pointed out that b ions may initially appear as proton-
ated oxazolones. It is doubtful that this structure would
describe bn ion structures with n $ 3 correctly. B ions
are known to undergo metastable decompositions [40],
i.e., the b5 fragment ion with the sequence Pyr–Leu–
Asn–Phe–Thr of locust adipokinetic hormone (AKH)
was completely sequenced in a mass spectrometric
experiment by metastable decompositions [41]. This
observation demonstrated the presence of a nonlocal-
ized proton in this peptide fragment, otherwise the
decomposition would require high energy CID as
known for remote-charge fragmentations [42]. There-
fore, bn ions for n $ 3 may exist in multiple isomeric
structures which allow the proton residing on carbonyl
groups on the peptide backbone or the N-terminal
amino group.
Relevance for Structural Analysis of Peptides
The discrimination between the N- and the C-terminal
ends of inner chain fragments, which were observed for
example in the low energy CID mass spectra of ES- or
FAB-ionized linear peptides [43, 44] and especially for
Pro containing sequences [45] (Scheme Ib) can represent
a severe problem [40], because loss of a neutral amino
acid residue cannot be unambiguously referred to the
N- or C-terminal localization of this amino acid [40].
Analysis of a b2 ion fragment, which represents a part of
an inner chain peptide fragment, can be used to distin-
guish both ends of the inner chain fragment by the CID
mass spectral assignment of the b2 ion sequence.
Many fragments of protonated cyclic peptides ob-
served in the CID mass spectra have been assigned to
the b ion type [8]. One general strategy used the
occurrence of b2 ions in the CID mass spectra of cyclic
peptides ionized by ES or FAB to deduce the connec-
tivity between amino acid residues without the C- or
N-terminal orientation in cyclic peptides [40]. Different
strategies were provided for the discrimination be-
tween the resulting cyclic peptide sequence and retro-
sequence [40, 46]. The results on b2 ions presented here
can be used to determine unequivocally the correct
amino acid residue orientation in cyclic peptides on the
basis of each b2 ion fragment. A similar approach was
applied during the mass spectrometric investigations of
the cyclic peptide gramicidin S. The CID mass spectrum
of the m/z 197 fragment derived from FAB-ionized
gramicidin S was compared with the CID mass spectra
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of the Pro–Val and Val–Pro b2 ions (m/z 197), which
were obtained by EI of the corresponding methyl esters.
On this basis the sequence Pro–Val was assigned to the
m/z 197 fragment, and the entire sequence could be
determined correctly [47].
Conclusion
B2 ions containing Ala, Gly, Pro, and Sar were subjected
to H/D exchange and analyzed with high energy CID.
The structures suggested on the basis of these experi-
ments were in agreement with quantum chemical cal-
culations. The immonium ion structure of b2 ions was
attributed to heteromeric sequences carrying the more
basic residue at the N-terminus, whereas the reversed
sequences, which were usually observed in greater
abundance than the former sequences, gave rise to
stable oxazolone structures. No CO2 loss was found for
the protonated oxazolone type b2 ion structures. The
CID mass spectra of the immonium ion type b2 ions
exhibited exclusively the immonium ion fragment of
the N-terminal amino acid residue, whereas the proton-
ated oxazolone type b2 ions provided immonium ion
fragments of both amino acid residues. Thus, the N-
versus C-terminus in b2 fragment ions of different
origin can be assigned. On this basis, the discrimination
between the sequence and retrosequence of cyclic pep-
tides is possible.
It was demonstrated that N-alkylation of a particular
amide group enhanced the cleavage of the next C-
terminally located amide bond. This observation in
combination with the results of the H/D exchange
experiments pointed to an initial formation of b2 ions
with the protonated oxazolone structure which may
then rearrange to the immonium ion structure in the
case of its greater stability.
H/D exchange experiments permitted a clear dis-
crimination between the acidic and nonacidic hydro-
gens during CID. Under high energy CID conditions,
the y2a2 immonium ion fragment of the amino acid
being part of the oxazolone moiety was not formed by
fragmentation via a stable a2 ion intermediate as shown
by the appearance of a primary kinetic isotope effect.
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